相关实验视频

Updated: May 30, 2025

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

Published on: June 23, 2009

与塞马格卢提德相关的肌肤敏感:一个病例系列

Jennifer Stark¹, Marian J Klass², Lauren Owen¹

¹Veterans Health Care System of the Ozarks, Fayetteville, AR, USA.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

|January 25, 2025

概括

类似葡萄糖类-1受体激动剂 (GLP-1RA) 药物,如塞马格卢提德,可能会导致全氨,疼痛的皮肤感觉. 这项研究报告了四起与更高剂量西马格卢提德用于体重管理有关的病例.

科学领域:

药理学药理学是指药理学的学科.
皮肤病学皮肤病学
内分泌学在内分泌学.

背景情况:

类似葡萄糖-1受体激动剂 (GLP-1RAs) 通常用于糖尿病和肥胖症.
虽然有报道罕见的皮肤过敏症,但GLP-1RA使用之前没有记录过Allodynia.

研究的目的:

为了报告与塞马格卢提德相关的全发性病例,GLP-1RA.
为了研究塞马格卢提德剂量与全体的发展之间的关系.

主要方法:

一系列病例报告了四名患有全体症的患者.
评估症状发作,剂量升级和治疗结果.
使用Naranjo尺度来评估因果关系.

主要成果:

四名患者在接受2.4毫克皮下每周剂量的西马格卢提德用于肥胖管理时,出现了全发性.
两名患者在停止服用西马格卢类药物后出现症状缓解.
一名患者在持续使用四个月后症状消失;没有确定药理机制.

结论:

一个时间和剂量-反应关系表明,塞马格卢提德可能会导致全.
需要进一步调查,以确定这是否是一种类效应,以及症状是否始终消失.
在这些案例中,纳兰乔尺度表明了semaglutide和allodynia之间可能存在联系.

关键词:

药物不良反应药物不良反应亚洛迪尼亚 (allodynia) 是一种全气体的现象.葡萄糖类-1受体激动剂的葡萄糖类-1受体激动剂塞马格卢提德 (semaglutide) 是一种可怕的药物.

更多相关视频

Acute and Chronic Tactile Sensory Testing after Spinal Cord Injury in Rats

Acute and Chronic Tactile Sensory Testing after Spinal Cord Injury in Rats

Published on: April 4, 2012

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...